Quarterly report · Q2

Period2023-12-01 → 2024-05-31
Filed2024-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2023-12-01 → 2024-05-31Cons.Net sales
Revenue¥8.6bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥4.2bn2022-12-01 → 2023-05-31Cons.Net sales
Operating income¥202m2023-12-01 → 2024-05-31Cons.Operating income
Operating income¥156m2022-12-01 → 2023-05-31Cons.Operating income
Ordinary income¥212m2023-12-01 → 2024-05-31Cons.Ordinary income
Ordinary income¥345m2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥156m2022-12-01 → 2023-05-31Cons.Ordinary income
Profit before tax¥252m2023-12-01 → 2024-05-31Cons.Income before income taxes
Profit before tax¥155m2022-12-01 → 2023-05-31Cons.Income before income taxes
Net income (owners)¥193m2023-12-01 → 2024-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥256m2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥121m2022-12-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income¥193m2023-12-01 → 2024-05-31Cons.Profit loss
Net income¥121m2022-12-01 → 2023-05-31Cons.Profit loss
Total assets¥8.0bnat 2024-05-31Cons.Assets
Total assets¥8.3bnat 2023-11-30Cons.Assets
Total assets¥8.0bnat 2023-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.3bnat 2024-05-31Cons.Liabilities
Total liabilities¥5.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥2.7bnat 2024-05-31Cons.Net assets
Net assets / equity¥2.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥2.5bnat 2023-05-31Cons.Net assets (5-year summary)
Cash and deposits¥947mat 2024-05-31Cons.Cash and deposits
Cash and deposits¥1.0bnat 2023-11-30Cons.Cash and deposits
Cash & equivalents¥947mat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.0bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥999mat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2022-11-30dCons.Cash and cash equivalents
Operating cash flow¥90m2023-12-01 → 2024-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥470m2022-12-01 → 2023-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥223m2022-12-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥96m2023-12-01 → 2024-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥370m2022-12-01 → 2023-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥217m2022-12-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥101m2023-12-01 → 2024-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥21m2022-12-01 → 2023-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥80m2022-12-01 → 2023-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥158.382023-12-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥117.592024-03-01 → 2024-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥209.882022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥99.172022-12-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.392023-03-01 → 2023-05-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio34.2%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.6%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2023-12-01 → 2024-05-31¥187m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2023-12-01 → 2024-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-05-31¥202m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-05-31¥141m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-05-31¥156m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Other nclPrior1YearInstant130545000JPY
Other nclCurrentQuarterInstant121914000JPY
Noncurrent liabilitiesPrior1YearInstant940246000JPY
Noncurrent liabilitiesCurrentQuarterInstant1204065000JPY
LiabilitiesPrior1YearInstant5702170000JPY
LiabilitiesCurrentQuarterInstant5292159000JPY
Capital stockPrior1YearInstant610000000JPY
Capital stockCurrentQuarterInstant610000000JPY
Capital surplusPrior1YearInstant58437000JPY
Capital surplusCurrentQuarterInstant58437000JPY
Retained earningsPrior1YearInstant1881096000JPY
Retained earningsCurrentQuarterInstant2013050000JPY
Treasury stockPrior1YearInstant-8202000JPY
Treasury stockCurrentQuarterInstant-8202000JPY
Shareholders equityPrior1YearInstant2541332000JPY
Shareholders equityCurrentQuarterInstant2673286000JPY
Valuation difference on available for sale securitiesPrior1YearInstant46890000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant15981000JPY
Foreign currency translation adjustmentPrior1YearInstant50201000JPY
Foreign currency translation adjustmentCurrentQuarterInstant60362000JPY
Valuation and translation adjustmentsPrior1YearInstant97091000JPY
Valuation and translation adjustmentsCurrentQuarterInstant76343000JPY
Net assetsPrior1YearInstant2638424000JPY
Net assetsCurrentQuarterInstant2749629000JPY
Liabilities and net assetsPrior1YearInstant8340594000JPY
Liabilities and net assetsCurrentQuarterInstant8041789000JPY
Net salesPrior1YTDDuration4206904000JPY
Net salesCurrentYTDDuration4248278000JPY
Cost of salesPrior1YTDDuration3491200000JPY
Cost of salesCurrentYTDDuration3470153000JPY
Gross profitPrior1YTDDuration715704000JPY
Gross profitCurrentYTDDuration778125000JPY
Selling general and administrative expensesPrior1YTDDuration559348000JPY
Selling general and administrative expensesCurrentYTDDuration575706000JPY
Operating incomePrior1YTDDuration156355000JPY
Operating incomeCurrentYTDDuration202418000JPY
Interest income noiPrior1YTDDuration1216000JPY
Interest income noiCurrentYTDDuration1521000JPY
Dividends income noiPrior1YTDDuration1371000JPY
Dividends income noiCurrentYTDDuration1095000JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration329000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration637000JPY
Foreign exchange gains noiPrior1YTDDuration24000JPY
Foreign exchange gains noiCurrentYTDDuration3222000JPY
Compensation income noiPrior1YTDDuration1763000JPY
Compensation income noiCurrentYTDDuration-JPY
Income from contribution to facilities noiPrior1YTDDuration-JPY
Income from contribution to facilities noiCurrentYTDDuration10000000JPY
Other noiPrior1YTDDuration4105000JPY
Other noiCurrentYTDDuration2798000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-11-30pass
balance sheet identityconsolidated 2024-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-05-31pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2023-12-01/2024-05-31pass
statement vs summary · revenueconsolidated 2022-12-01/2023-05-31pass
statement vs summary · revenueconsolidated 2023-12-01/2024-05-31pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-05-31pass